Nomura Holdings’s Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share IBER.WS Stock Holding History

Nomura Holdings’s Portfolio IBER.WS Stock Details IBER.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-141,843	Closed	-$16K	–	1924
2022 Q4	$16K	Hold	141,843	–	–	﹤0.01%	1329
2022 Q3	$21K	Hold	141,843	–	–	﹤0.01%	1471
2022 Q2	$28K	Hold	141,843	–	–	﹤0.01%	1572
2022 Q1	$41K	Hold	141,843	–	–	﹤0.01%	1782
2021 Q4	$78K	Hold	141,843	–	–	﹤0.01%	2018
2021 Q3	$83K	Hold	141,843	–	–	﹤0.01%	1798
2021 Q2	$96K	Buy	+141,843	New	+$86.1K	﹤0.01%	1833

Other funds holding IBER.WS

LCM

Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return

Nomura Holdings's IBER.WS Position: Q1 2023 in Review

Nomura Holdings sold out of Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (IBER.WS) in Q1 2023, closing a stake of 141,843 shares — an estimated $16K sold.

Nomura Holdings first reported a position in IBER.WS in Q2 2021 and held it in 7 quarters. The position peaked at $96K in Q2 2021. 1 fund tracked by Wall St. Rank holds IBER.WS as of Q1 2023.

Nomura Holdings reported no remaining Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q1 2023 after selling out during the quarter.
Nomura Holdings sold 141,843 Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q1 2023, an estimated $16K.
Nomura Holdings first reported a position in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q2 2021 and held it in 7 quarters.
Nomura Holdings's Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $96K in Q2 2021.
1 fund tracked by Wall St. Rank held Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q1 2023.

Based on Nomura Holdings's 13F filing for Q1 2023, filed 15 May 2023.